These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2219765)

  • 1. [Tenoxicam in the long-term treatment of active rheumatoid arthritis].
    Vachtenheim J
    Vnitr Lek; 1990 Jun; 36(6):580-5. PubMed ID: 2219765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the occurrence of gastrointestinal side-effects of tenoxicam and other nonsteroidal antirheumatic agents in patients with rheumatoid arthritis].
    Vlak T; Jajić I; Bilić A
    Reumatizam; 1996; 43(1):1-9. PubMed ID: 8966374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of tenoxicam and piroxicam in the treatment of rheumatoid arthritis.
    Atkinson M; Khanna V; Ménard H; Russel AS; Tannenbaum H
    J Rheumatol; 1992 Apr; 19(4):538-42. PubMed ID: 1593574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenoxicam, a new non-steroidal anti-inflammatory drug in the prolonged treatment of rheumatoid arthritis.
    Gentiletti AA
    Eur J Rheumatol Inflamm; 1987; 9(2):91-4. PubMed ID: 3329116
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of rheumatoid arthritis: results of a two-year study with tenoxicam.
    Gross W
    Eur J Rheumatol Inflamm; 1987; 9(2):102-4. PubMed ID: 3329098
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term study with Ro 12-0068 (tenoxicam) in the treatment of rheumatoid arthritis.
    Mathias Filho AP; Sidi A
    Eur J Rheumatol Inflamm; 1985; 8(1):3-8. PubMed ID: 3915886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
    Havranek H
    Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of tenoxicam (Tilcotil, Mobiflex) at two doses against ibuprofen in rheumatoid arthritis.
    Bird HA; Hill J; Lowe JR; Wright V
    Eur J Rheumatol Inflamm; 1984; 7(2):28-32. PubMed ID: 6400518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice.
    Langdon CG; Moran DG; Jamieson V; Spence S; Hill SA
    J Int Med Res; 1990; 18(6):489-96. PubMed ID: 2292331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large multicentre, parallel group, double-blind study comparing tenoxicam and piroxicam in the treatment of osteoarthritis and rheumatoid arthritis.
    Simpson J; Golding DN; Freeman AM; Cooke D; Hooper PA; Jamieson V; Osborne C
    Br J Clin Pract; 1989 Sep; 43(9):328-33. PubMed ID: 2695152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal administration of tenoxicam for the treatment of rheumatoid arthritis and arthrosis.
    Fiszman P; Perpétuo JB; Franco JS; Pernambuco JC; Rubinstein J; Sidi A
    Eur J Rheumatol Inflamm; 1985; 8(1):9-14. PubMed ID: 3915889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term study with tenoxicam in rheumatoid arthritis.
    Fiszman P; Perpétuo JB; Sidi A
    Eur J Rheumatol Inflamm; 1987; 9(2):86-90. PubMed ID: 3329115
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term study on the efficacy and safety of lornoxicam in rheumatoid arthritis].
    Frizziero L; Focherini MC; Valentini M; Reta M; Rocchi P
    Minerva Med; 2002 Aug; 93(4):315-20. PubMed ID: 12207202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with tenoxicam in rheumatoid arthritis.
    Orozco-Alcalá JJ; Barrera-Tenorio EF
    Eur J Rheumatol Inflamm; 1987; 9(2):118-21. PubMed ID: 3329102
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of tenoxicam in osteoarthrosis, rheumatoid arthritis and ankylosing spondylitis.
    Standel W; Josenhants G
    Eur J Rheumatol Inflamm; 1985; 8(1):28-38. PubMed ID: 3915885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of tenoxicam and piroxicam on grip strength in patients with rheumatoid arthritis.
    O'Brien K; Essigman WK; Little S
    Scand J Rheumatol Suppl; 1989; 80():81-5. PubMed ID: 2595345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and tolerability of tenoxicam in African patients with osteoarthritis, rheumatoid arthritis, tendinitis and/or bursitis: an open study.
    Ibrahima K; Kodjo G; Issa S; Seye L; Cisse F; Eassey G; Rietiker S
    Curr Med Res Opin; 1991; 12(7):471-8. PubMed ID: 1778090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term (four year) clinical trial with tenoxicam and basis therapy in patients suffering from rheumatoid arthritis.
    Lalos J; Tsachalos P; Gallis L
    Scand J Rheumatol Suppl; 1989; 80():67-70. PubMed ID: 2512637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.